Subscribe To
Rocket pharmaceuticals: 2 regulatory filings in 2023 could propel it higher
A Rocket Pharmaceuticals, Inc. regulatory filing to the FDA of LV RP-L201 for Leukocyte Adhesion Deficiency-I is expected in the 1st half of 2023. A r...
November 29, 2022, 10:50 am
Sanofi's (sny) rare anemia drug enjaymo gets eu approval
Sanofi's (SNY) Enjaymo gets approval to treat hemolytic anemia in adult patients with cold agglutinin d...
November 18, 2022, 1:41 pm
Rockwell medical receives additional fda feedback on anemia candidate
Last week, Rockwell Medical Inc (NASDAQ: RMTI) closed the second $7.5 million tranche of the previously announced DaVita Inc (NYSE: DVA) stock p...
June 23, 2022, 7:21 am
Rigel (rigl) waiha study fails to meet goals, stock tanks
Rigel (RIGL) phase III study evaluating fostamatinib in patients with warm autoimmune hemolytic anemia ...
June 9, 2022, 2:17 pm
Rockwell medical to present at noblecon18 investor conference
WIXOM, Mich. , April 20, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company...
April 20, 2022, 8:00 am
Fda rejects akebia therapeutics' vadadustat for ckd-associated anemia
The FDA has issued a complete response letter (CRL) to Akebia Therapeutics Inc's (NASDAQ: AKBA) marketing application (NDA) for vadadustat for
March 30, 2022, 3:42 pm
Fda approves agios' mitapivat as first disease-modifying therapy for genetic blood disorder
The FDA approved Agios Pharmaceuticals Inc's (NASDAQ: AGIO) Pyrukynd (mitapivat) for hemolytic anemia ...
February 18, 2022, 5:41 am
Fda approves agios' mitapivat as first disease-modifying therapy for genetic blood disorder
The FDA approved Agios Pharmaceuticals Inc's (NASDAQ: AGIO) Pyrukynd (mitapivat) for hemolytic anemia ...
February 18, 2022, 5:41 am
Fda approves agios' mitapivat as first disease-modifying therapy for genetic blood disorder
The FDA approved Agios Pharmaceuticals Inc's (NASDAQ: AGIO) Pyrukynd (mitapivat) for hemolytic anemia ...
February 18, 2022, 5:41 am
Global blood therapeutics' oxbryta scores european approval for sickle cell disease
The European Commission (EC) has approved Global Blood Therapeutics Inc's (NASDAQ: GBT) Oxbryta (voxelotor) for hemolytic ...
February 16, 2022, 9:41 am
Global blood therapeutics' oxbryta scores european approval for sickle cell disease
The European Commission (EC) has approved Global Blood Therapeutics Inc's (NASDAQ: GBT) Oxbryta (voxelotor) for hemolytic ...
February 16, 2022, 9:41 am
Global blood therapeutics' oxbryta scores european approval for sickle cell disease
The European Commission (EC) has approved Global Blood Therapeutics Inc's (NASDAQ: GBT) Oxbryta (voxelotor) for hemolytic ...
February 16, 2022, 9:41 am
Rockwell medical, inc. to present at aegis virtual conference
WIXOM, Mich., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutic...
February 15, 2022, 8:30 am
Rockwell medical, inc. to present at aegis virtual conference
WIXOM, Mich., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutic...
February 15, 2022, 8:30 am
Rockwell medical, inc. to present at aegis virtual conference
WIXOM, Mich., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutic...
February 15, 2022, 8:30 am